Ischemia & Reperfusion

Ischemia and reperfusion is a pathological condition characterized by an initial restriction of blood supply to an organ followed by the subsequent restoration of perfusion and concomitant reoxygenation. Restoration of blood flow and reoxygenation is frequently associated with an exacerbation of tissue injury and a profound inflammatory response (called ‘reperfusion injury’). Discover the latest research on ischemia and reperfusion here.

January 21, 2022
Open Access

Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes.

Oxidative Medicine and Cellular Longevity
Xiaoling MaXiaoning Ma
January 21, 2022
Open Access

miR-3587 Inhibitor Attenuates Ferroptosis Following Renal Ischemia-Reperfusion Through HO-1.

Frontiers in Molecular Biosciences
Wenqiang TaoKejian Qian
January 21, 2022

The effects of etomidate on testicular ischemia reperfusion injury in ipsilateral and contralateral testes of rats.

European Review for Medical and Pharmacological Sciences
M Jafarova DemirkapuH R Yananli
January 21, 2022

Gastrodin Pretreatment Alleviates Renal Ischemia-Reperfusion Injury.

Urologia Internationalis
Yi ZhengFuding Bai
January 20, 2022
Preprint
Open Access

HuR-dependent expression of Wisp1 is necessary for TGF????-induced cardiac myofibroblast activity

BioRxiv : the Preprint Server for Biology
L. C. GreenMichael Tranter
January 20, 2022

Efficacy of Nitric Oxide-Releasing Nanofibers in Reducing Renal Ischemia-Reperfusion Injury in a Rat Model.

Annals of Transplantation : Quarterly of the Polish Transplantation Society
Hyunmin KoHyung Joon Ahn
January 20, 2022

Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Shichun ShenLikun Ma
January 20, 2022

Pathophysiology of intraabdominal hypertension and abdominal compartment syndrome and relevance to veterinary critical care.

Journal of Veterinary Emergency and Critical Care
Alison K Gardner, Eric L Schroeder
January 20, 2022

Reversing mitochondrial defects in aged hearts: Role of mitochondrial calpain activation.

American Journal of Physiology. Cell Physiology
Qun ChenEdward J Lesnefsky
January 19, 2022

Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials.

Circulation. Cardiovascular Quality and Outcomes
Flavien VincentPhilippe Pibarot
January 19, 2022

A-kinase Anchoring Protein 5 Anchors Protein Kinase A to Mediate PLN/SERCA to Reduce Cardiomyocyte Apoptosis Induced by Hypoxia and Reoxygenation.

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
Zhi WangHegui Wang
January 19, 2022
Review

Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases.

Inflammopharmacology
Fang HuaPeng Zhou

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved
/feed-previews/ischemia-reperfusion/7a35500c-386f-45d6-b7f0-2b08ef7fa8d2